Skip to main content
. 2019 Jul 9;26(3):429–439. doi: 10.1093/ibd/izz143

FIGURE 4.

FIGURE 4.

Model-based prediction of infliximab concentrations with different dosing strategies in a simulated standard patient (weight 65 kg, ALB 3.5 g/dL, ATI <22 ng/mL, ESR 9 mm/h). The green line denotes an IFX target concentration of 5 µg/mL. A, A fixed interval of 8 weeks and IFX doses of 5 mg/kg, 7.5 mg/kg, and 10 mg/kg, respectively. B, A fixed IFX dose of 5 mg/kg and intervals of 4, 6, and 8 weeks, respectively.